secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2023-07-11T23:59:59+00:00
Accession:  0001213900-23-056196
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity raises ~$11M in public offering; reprices warrants, reduces Series A conversion price, redeems 3i holdings
--------------------------------------------------------------------------------

- Public offering of 357,223 shares, pre-funded warrants for 2,087,222 shares, and common warrants for 2,444,445 shares at $4.50 combined price, gross proceeds ~$11M.
- Concurrent with offering, repriced April 2023 common warrants exercise price to $4.50 and extended expiry to July 10, 2028.
- Converted Series A Preferred Stock conversion price reduced from $8.00 to $4.50.
- Using offering proceeds, redeemed 4,630 Series A Preferred shares from 3i, LP for $5,000,400 and a $350,000 secured note for $350,886.
- Placement agent A.G.P./Alliance Global Partners received 7% cash fee plus up to $150,000 expenses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023056196/0001213900-23-056196-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023056196/ea181570-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-056196

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer